Investing

Precigen : PGEN

PGEN

Stock Data

$5.14

$0.32 (6.64%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Precigen, Inc., originally known as Intrexon Corporation, is a biopharmaceutical company based in Germantown, Maryland, focusing on developing gene and cell therapies. With a foundation laid in 1998, Precigen advances treatments for a variety of diseases, including those in immuno-oncology, autoimmune disorders, and infectious diseases. The company's innovative precision technology propels its pipeline of preclinical and clinical therapies towards commercialization, aiming to revolutionize biotherapeutic solutions.

All Precigen Articles

2 Articles

Joshua Rodriguez | Aug 30, 2024 at 10:20 AM EDT

3 Penny Stocks to Buy With $500

Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions…

Trey Thoelcke | Aug 18, 2024 at 9:15 AM EDT

10% Owner Funds Trucking Acquisition, Plus More Big Insider Buying

A beneficial owner made a huge buy of shares in a trucking company this past week. That was not the only…